Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials
Peter Ch'en
Guru | Medical student Dermatology, Cutaneous Oncology
Presented at: Society for Investigative Dermatology 2025
Date: 2025-05-07 00:00:00
Views: 26
Summary: Content is hidden. So this is just placeholder text should someone try to view the source of the content. You thought you could get away with it, didn't you? Now look at you just continuing to scroll. Have a great day!